Global Antisense Oligonucleotides (ASO) Therapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases
The global Antisense Oligonucleotides (ASO) Therapy market size is projected to grow from US$ 3938 million in 2024 to US$ 10620 million in 2030; it is expected to grow at a CAGR of 18.0% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Antisense Oligonucleotides (ASO) Therapy Industry Forecast” looks at past sales and reviews total world Antisense Oligonucleotides (ASO) Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Antisense Oligonucleotides (ASO) Therapy sales for 2023 through 2029. With Antisense Oligonucleotides (ASO) Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antisense Oligonucleotides (ASO) Therapy industry.
This Insight Report provides a comprehensive analysis of the global Antisense Oligonucleotides (ASO) Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antisense Oligonucleotides (ASO) Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antisense Oligonucleotides (ASO) Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antisense Oligonucleotides (ASO) Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antisense Oligonucleotides (ASO) Therapy.
United States market for Antisense Oligonucleotides (ASO) Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Antisense Oligonucleotides (ASO) Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Antisense Oligonucleotides (ASO) Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Antisense Oligonucleotides (ASO) Therapy players cover Ionis Pharmaceuticals, Biogen, Sobi, Nippon Shinyaku, Jazz Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Antisense Oligonucleotides (ASO) Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases
The global Antisense Oligonucleotides (ASO) Therapy market size is projected to grow from US$ 3938 million in 2024 to US$ 10620 million in 2030; it is expected to grow at a CAGR of 18.0% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Antisense Oligonucleotides (ASO) Therapy Industry Forecast” looks at past sales and reviews total world Antisense Oligonucleotides (ASO) Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Antisense Oligonucleotides (ASO) Therapy sales for 2023 through 2029. With Antisense Oligonucleotides (ASO) Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antisense Oligonucleotides (ASO) Therapy industry.
This Insight Report provides a comprehensive analysis of the global Antisense Oligonucleotides (ASO) Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antisense Oligonucleotides (ASO) Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antisense Oligonucleotides (ASO) Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antisense Oligonucleotides (ASO) Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antisense Oligonucleotides (ASO) Therapy.
United States market for Antisense Oligonucleotides (ASO) Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Antisense Oligonucleotides (ASO) Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Antisense Oligonucleotides (ASO) Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Antisense Oligonucleotides (ASO) Therapy players cover Ionis Pharmaceuticals, Biogen, Sobi, Nippon Shinyaku, Jazz Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Antisense Oligonucleotides (ASO) Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Intrathecal Injection
- Intravenous Injections
- Other
- Neuromuscular Diseases
- hATTR
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Intrathecal Injection
- Intravenous Injections
- Other
- Neuromuscular Diseases
- hATTR
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ionis Pharmaceuticals
- Biogen
- Sobi
- Nippon Shinyaku
- Jazz Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antisense Oligonucleotides (ASO) Therapy Market Size 2019-2030
2.1.2 Antisense Oligonucleotides (ASO) Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Antisense Oligonucleotides (ASO) Therapy by Country/Region, 2019, 2023 & 2030
2.2 Antisense Oligonucleotides (ASO) Therapy Segment by Type
2.2.1 Intrathecal Injection
2.2.2 Intravenous Injections
2.2.3 Other
2.3 Antisense Oligonucleotides (ASO) Therapy Market Size by Type
2.3.1 Antisense Oligonucleotides (ASO) Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2019-2024)
2.4 Antisense Oligonucleotides (ASO) Therapy Segment by Application
2.4.1 Neuromuscular Diseases
2.4.2 hATTR
2.4.3 Other
2.5 Antisense Oligonucleotides (ASO) Therapy Market Size by Application
2.5.1 Antisense Oligonucleotides (ASO) Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2024)
3 ANTISENSE OLIGONUCLEOTIDES (ASO) THERAPY MARKET SIZE BY PLAYER
3.1 Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Player
3.1.1 Global Antisense Oligonucleotides (ASO) Therapy Revenue by Player (2019-2024)
3.1.2 Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Player (2019-2024)
3.2 Global Antisense Oligonucleotides (ASO) Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTISENSE OLIGONUCLEOTIDES (ASO) THERAPY BY REGION
4.1 Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2019-2024)
4.2 Global Antisense Oligonucleotides (ASO) Therapy Annual Revenue by Country/Region (2019-2024)
4.3 Americas Antisense Oligonucleotides (ASO) Therapy Market Size Growth (2019-2024)
4.4 APAC Antisense Oligonucleotides (ASO) Therapy Market Size Growth (2019-2024)
4.5 Europe Antisense Oligonucleotides (ASO) Therapy Market Size Growth (2019-2024)
4.6 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2019-2024)
5.2 Americas Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024)
5.3 Americas Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2019-2024)
6.2 APAC Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024)
6.3 APAC Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2019-2024)
7.2 Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024)
7.3 Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy by Region (2019-2024)
8.2 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTISENSE OLIGONUCLEOTIDES (ASO) THERAPY MARKET FORECAST
10.1 Global Antisense Oligonucleotides (ASO) Therapy Forecast by Region (2025-2030)
10.1.1 Global Antisense Oligonucleotides (ASO) Therapy Forecast by Region (2025-2030)
10.1.2 Americas Antisense Oligonucleotides (ASO) Therapy Forecast
10.1.3 APAC Antisense Oligonucleotides (ASO) Therapy Forecast
10.1.4 Europe Antisense Oligonucleotides (ASO) Therapy Forecast
10.1.5 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Forecast
10.2 Americas Antisense Oligonucleotides (ASO) Therapy Forecast by Country (2025-2030)
10.2.1 United States Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.2.2 Canada Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.2.3 Mexico Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.2.4 Brazil Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.3 APAC Antisense Oligonucleotides (ASO) Therapy Forecast by Region (2025-2030)
10.3.1 China Antisense Oligonucleotides (ASO) Therapy Market Forecast
10.3.2 Japan Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.3.3 Korea Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.3.4 Southeast Asia Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.3.5 India Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.3.6 Australia Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.4 Europe Antisense Oligonucleotides (ASO) Therapy Forecast by Country (2025-2030)
10.4.1 Germany Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.4.2 France Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.4.3 UK Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.4.4 Italy Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.4.5 Russia Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.5 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.5.2 South Africa Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.5.3 Israel Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.5.4 Turkey Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.6 Global Antisense Oligonucleotides (ASO) Therapy Forecast by Type (2025-2030)
10.7 Global Antisense Oligonucleotides (ASO) Therapy Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Antisense Oligonucleotides (ASO) Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Ionis Pharmaceuticals
11.1.1 Ionis Pharmaceuticals Company Information
11.1.2 Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product Offered
11.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Ionis Pharmaceuticals Main Business Overview
11.1.5 Ionis Pharmaceuticals Latest Developments
11.2 Biogen
11.2.1 Biogen Company Information
11.2.2 Biogen Antisense Oligonucleotides (ASO) Therapy Product Offered
11.2.3 Biogen Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Biogen Main Business Overview
11.2.5 Biogen Latest Developments
11.3 Sobi
11.3.1 Sobi Company Information
11.3.2 Sobi Antisense Oligonucleotides (ASO) Therapy Product Offered
11.3.3 Sobi Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sobi Main Business Overview
11.3.5 Sobi Latest Developments
11.4 Nippon Shinyaku
11.4.1 Nippon Shinyaku Company Information
11.4.2 Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Product Offered
11.4.3 Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Nippon Shinyaku Main Business Overview
11.4.5 Nippon Shinyaku Latest Developments
11.5 Jazz Pharmaceuticals
11.5.1 Jazz Pharmaceuticals Company Information
11.5.2 Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product Offered
11.5.3 Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Jazz Pharmaceuticals Main Business Overview
11.5.5 Jazz Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antisense Oligonucleotides (ASO) Therapy Market Size 2019-2030
2.1.2 Antisense Oligonucleotides (ASO) Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Antisense Oligonucleotides (ASO) Therapy by Country/Region, 2019, 2023 & 2030
2.2 Antisense Oligonucleotides (ASO) Therapy Segment by Type
2.2.1 Intrathecal Injection
2.2.2 Intravenous Injections
2.2.3 Other
2.3 Antisense Oligonucleotides (ASO) Therapy Market Size by Type
2.3.1 Antisense Oligonucleotides (ASO) Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2019-2024)
2.4 Antisense Oligonucleotides (ASO) Therapy Segment by Application
2.4.1 Neuromuscular Diseases
2.4.2 hATTR
2.4.3 Other
2.5 Antisense Oligonucleotides (ASO) Therapy Market Size by Application
2.5.1 Antisense Oligonucleotides (ASO) Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2024)
3 ANTISENSE OLIGONUCLEOTIDES (ASO) THERAPY MARKET SIZE BY PLAYER
3.1 Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Player
3.1.1 Global Antisense Oligonucleotides (ASO) Therapy Revenue by Player (2019-2024)
3.1.2 Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Player (2019-2024)
3.2 Global Antisense Oligonucleotides (ASO) Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTISENSE OLIGONUCLEOTIDES (ASO) THERAPY BY REGION
4.1 Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2019-2024)
4.2 Global Antisense Oligonucleotides (ASO) Therapy Annual Revenue by Country/Region (2019-2024)
4.3 Americas Antisense Oligonucleotides (ASO) Therapy Market Size Growth (2019-2024)
4.4 APAC Antisense Oligonucleotides (ASO) Therapy Market Size Growth (2019-2024)
4.5 Europe Antisense Oligonucleotides (ASO) Therapy Market Size Growth (2019-2024)
4.6 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2019-2024)
5.2 Americas Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024)
5.3 Americas Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2019-2024)
6.2 APAC Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024)
6.3 APAC Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2019-2024)
7.2 Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024)
7.3 Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy by Region (2019-2024)
8.2 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTISENSE OLIGONUCLEOTIDES (ASO) THERAPY MARKET FORECAST
10.1 Global Antisense Oligonucleotides (ASO) Therapy Forecast by Region (2025-2030)
10.1.1 Global Antisense Oligonucleotides (ASO) Therapy Forecast by Region (2025-2030)
10.1.2 Americas Antisense Oligonucleotides (ASO) Therapy Forecast
10.1.3 APAC Antisense Oligonucleotides (ASO) Therapy Forecast
10.1.4 Europe Antisense Oligonucleotides (ASO) Therapy Forecast
10.1.5 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Forecast
10.2 Americas Antisense Oligonucleotides (ASO) Therapy Forecast by Country (2025-2030)
10.2.1 United States Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.2.2 Canada Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.2.3 Mexico Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.2.4 Brazil Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.3 APAC Antisense Oligonucleotides (ASO) Therapy Forecast by Region (2025-2030)
10.3.1 China Antisense Oligonucleotides (ASO) Therapy Market Forecast
10.3.2 Japan Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.3.3 Korea Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.3.4 Southeast Asia Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.3.5 India Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.3.6 Australia Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.4 Europe Antisense Oligonucleotides (ASO) Therapy Forecast by Country (2025-2030)
10.4.1 Germany Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.4.2 France Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.4.3 UK Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.4.4 Italy Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.4.5 Russia Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.5 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.5.2 South Africa Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.5.3 Israel Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.5.4 Turkey Market Antisense Oligonucleotides (ASO) Therapy Forecast
10.6 Global Antisense Oligonucleotides (ASO) Therapy Forecast by Type (2025-2030)
10.7 Global Antisense Oligonucleotides (ASO) Therapy Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Antisense Oligonucleotides (ASO) Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Ionis Pharmaceuticals
11.1.1 Ionis Pharmaceuticals Company Information
11.1.2 Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product Offered
11.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Ionis Pharmaceuticals Main Business Overview
11.1.5 Ionis Pharmaceuticals Latest Developments
11.2 Biogen
11.2.1 Biogen Company Information
11.2.2 Biogen Antisense Oligonucleotides (ASO) Therapy Product Offered
11.2.3 Biogen Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Biogen Main Business Overview
11.2.5 Biogen Latest Developments
11.3 Sobi
11.3.1 Sobi Company Information
11.3.2 Sobi Antisense Oligonucleotides (ASO) Therapy Product Offered
11.3.3 Sobi Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sobi Main Business Overview
11.3.5 Sobi Latest Developments
11.4 Nippon Shinyaku
11.4.1 Nippon Shinyaku Company Information
11.4.2 Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Product Offered
11.4.3 Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Nippon Shinyaku Main Business Overview
11.4.5 Nippon Shinyaku Latest Developments
11.5 Jazz Pharmaceuticals
11.5.1 Jazz Pharmaceuticals Company Information
11.5.2 Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product Offered
11.5.3 Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Jazz Pharmaceuticals Main Business Overview
11.5.5 Jazz Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antisense Oligonucleotides (ASO) Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Antisense Oligonucleotides (ASO) Therapy Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Intrathecal Injection
Table 4. Major Players of Intravenous Injections
Table 5. Major Players of Other
Table 6. Antisense Oligonucleotides (ASO) Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2019-2024)
Table 9. Antisense Oligonucleotides (ASO) Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2024)
Table 12. Global Antisense Oligonucleotides (ASO) Therapy Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Player (2019-2024)
Table 14. Antisense Oligonucleotides (ASO) Therapy Key Players Head office and Products Offered
Table 15. Antisense Oligonucleotides (ASO) Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Region (2019-2024)
Table 20. Global Antisense Oligonucleotides (ASO) Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Country (2019-2024)
Table 24. Americas Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2019-2024)
Table 26. Americas Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2024)
Table 28. APAC Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Region (2019-2024)
Table 30. APAC Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Country (2019-2024)
Table 34. Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Antisense Oligonucleotides (ASO) Therapy
Table 40. Key Market Challenges & Risks of Antisense Oligonucleotides (ASO) Therapy
Table 41. Key Industry Trends of Antisense Oligonucleotides (ASO) Therapy
Table 42. Global Antisense Oligonucleotides (ASO) Therapy Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Antisense Oligonucleotides (ASO) Therapy Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Antisense Oligonucleotides (ASO) Therapy Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Ionis Pharmaceuticals Details, Company Type, Antisense Oligonucleotides (ASO) Therapy Area Served and Its Competitors
Table 47. Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product Offered
Table 48. Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Ionis Pharmaceuticals Main Business
Table 50. Ionis Pharmaceuticals Latest Developments
Table 51. Biogen Details, Company Type, Antisense Oligonucleotides (ASO) Therapy Area Served and Its Competitors
Table 52. Biogen Antisense Oligonucleotides (ASO) Therapy Product Offered
Table 53. Biogen Antisense Oligonucleotides (ASO) Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Sobi Details, Company Type, Antisense Oligonucleotides (ASO) Therapy Area Served and Its Competitors
Table 57. Sobi Antisense Oligonucleotides (ASO) Therapy Product Offered
Table 58. Sobi Antisense Oligonucleotides (ASO) Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Sobi Main Business
Table 60. Sobi Latest Developments
Table 61. Nippon Shinyaku Details, Company Type, Antisense Oligonucleotides (ASO) Therapy Area Served and Its Competitors
Table 62. Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Product Offered
Table 63. Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Nippon Shinyaku Main Business
Table 65. Nippon Shinyaku Latest Developments
Table 66. Jazz Pharmaceuticals Details, Company Type, Antisense Oligonucleotides (ASO) Therapy Area Served and Its Competitors
Table 67. Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product Offered
Table 68. Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Jazz Pharmaceuticals Main Business
Table 70. Jazz Pharmaceuticals Latest Developments
Table 1. Antisense Oligonucleotides (ASO) Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Antisense Oligonucleotides (ASO) Therapy Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Intrathecal Injection
Table 4. Major Players of Intravenous Injections
Table 5. Major Players of Other
Table 6. Antisense Oligonucleotides (ASO) Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2019-2024)
Table 9. Antisense Oligonucleotides (ASO) Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2024)
Table 12. Global Antisense Oligonucleotides (ASO) Therapy Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Player (2019-2024)
Table 14. Antisense Oligonucleotides (ASO) Therapy Key Players Head office and Products Offered
Table 15. Antisense Oligonucleotides (ASO) Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Region (2019-2024)
Table 20. Global Antisense Oligonucleotides (ASO) Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Country (2019-2024)
Table 24. Americas Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2019-2024)
Table 26. Americas Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2024)
Table 28. APAC Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Region (2019-2024)
Table 30. APAC Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Country (2019-2024)
Table 34. Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Antisense Oligonucleotides (ASO) Therapy
Table 40. Key Market Challenges & Risks of Antisense Oligonucleotides (ASO) Therapy
Table 41. Key Industry Trends of Antisense Oligonucleotides (ASO) Therapy
Table 42. Global Antisense Oligonucleotides (ASO) Therapy Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Antisense Oligonucleotides (ASO) Therapy Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Antisense Oligonucleotides (ASO) Therapy Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Ionis Pharmaceuticals Details, Company Type, Antisense Oligonucleotides (ASO) Therapy Area Served and Its Competitors
Table 47. Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product Offered
Table 48. Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Ionis Pharmaceuticals Main Business
Table 50. Ionis Pharmaceuticals Latest Developments
Table 51. Biogen Details, Company Type, Antisense Oligonucleotides (ASO) Therapy Area Served and Its Competitors
Table 52. Biogen Antisense Oligonucleotides (ASO) Therapy Product Offered
Table 53. Biogen Antisense Oligonucleotides (ASO) Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Sobi Details, Company Type, Antisense Oligonucleotides (ASO) Therapy Area Served and Its Competitors
Table 57. Sobi Antisense Oligonucleotides (ASO) Therapy Product Offered
Table 58. Sobi Antisense Oligonucleotides (ASO) Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Sobi Main Business
Table 60. Sobi Latest Developments
Table 61. Nippon Shinyaku Details, Company Type, Antisense Oligonucleotides (ASO) Therapy Area Served and Its Competitors
Table 62. Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Product Offered
Table 63. Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Nippon Shinyaku Main Business
Table 65. Nippon Shinyaku Latest Developments
Table 66. Jazz Pharmaceuticals Details, Company Type, Antisense Oligonucleotides (ASO) Therapy Area Served and Its Competitors
Table 67. Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product Offered
Table 68. Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Jazz Pharmaceuticals Main Business
Table 70. Jazz Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Antisense Oligonucleotides (ASO) Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Antisense Oligonucleotides (ASO) Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Antisense Oligonucleotides (ASO) Therapy Sales Market Share by Country/Region (2023)
Figure 8. Antisense Oligonucleotides (ASO) Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type in 2023
Figure 10. Antisense Oligonucleotides (ASO) Therapy in Neuromuscular Diseases
Figure 11. Global Antisense Oligonucleotides (ASO) Therapy Market: Neuromuscular Diseases (2019-2024) & ($ millions)
Figure 12. Antisense Oligonucleotides (ASO) Therapy in hATTR
Figure 13. Global Antisense Oligonucleotides (ASO) Therapy Market: hATTR (2019-2024) & ($ millions)
Figure 14. Antisense Oligonucleotides (ASO) Therapy in Other
Figure 15. Global Antisense Oligonucleotides (ASO) Therapy Market: Other (2019-2024) & ($ millions)
Figure 16. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application in 2023
Figure 17. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Player in 2023
Figure 18. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Region (2019-2024)
Figure 19. Americas Antisense Oligonucleotides (ASO) Therapy Market Size 2019-2024 ($ millions)
Figure 20. APAC Antisense Oligonucleotides (ASO) Therapy Market Size 2019-2024 ($ millions)
Figure 21. Europe Antisense Oligonucleotides (ASO) Therapy Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size 2019-2024 ($ millions)
Figure 23. Americas Antisense Oligonucleotides (ASO) Therapy Value Market Share by Country in 2023
Figure 24. United States Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Region in 2023
Figure 29. APAC Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2019-2024)
Figure 30. APAC Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2024)
Figure 31. China Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 35. India Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Country in 2023
Figure 38. Europe Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 41. France Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 54. APAC Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 55. Europe Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 57. United States Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 58. Canada Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 59. Mexico Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 60. Brazil Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 61. China Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 62. Japan Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 63. Korea Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 65. India Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 66. Australia Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 67. Germany Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 68. France Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 69. UK Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 70. Italy Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 71. Russia Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 72. Egypt Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 73. South Africa Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 74. Israel Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 75. Turkey Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 77. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Antisense Oligonucleotides (ASO) Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antisense Oligonucleotides (ASO) Therapy Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Antisense Oligonucleotides (ASO) Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Antisense Oligonucleotides (ASO) Therapy Sales Market Share by Country/Region (2023)
Figure 8. Antisense Oligonucleotides (ASO) Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type in 2023
Figure 10. Antisense Oligonucleotides (ASO) Therapy in Neuromuscular Diseases
Figure 11. Global Antisense Oligonucleotides (ASO) Therapy Market: Neuromuscular Diseases (2019-2024) & ($ millions)
Figure 12. Antisense Oligonucleotides (ASO) Therapy in hATTR
Figure 13. Global Antisense Oligonucleotides (ASO) Therapy Market: hATTR (2019-2024) & ($ millions)
Figure 14. Antisense Oligonucleotides (ASO) Therapy in Other
Figure 15. Global Antisense Oligonucleotides (ASO) Therapy Market: Other (2019-2024) & ($ millions)
Figure 16. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application in 2023
Figure 17. Global Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Player in 2023
Figure 18. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Region (2019-2024)
Figure 19. Americas Antisense Oligonucleotides (ASO) Therapy Market Size 2019-2024 ($ millions)
Figure 20. APAC Antisense Oligonucleotides (ASO) Therapy Market Size 2019-2024 ($ millions)
Figure 21. Europe Antisense Oligonucleotides (ASO) Therapy Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size 2019-2024 ($ millions)
Figure 23. Americas Antisense Oligonucleotides (ASO) Therapy Value Market Share by Country in 2023
Figure 24. United States Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Region in 2023
Figure 29. APAC Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2019-2024)
Figure 30. APAC Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2024)
Figure 31. China Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 35. India Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Country in 2023
Figure 38. Europe Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 41. France Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Antisense Oligonucleotides (ASO) Therapy Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 54. APAC Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 55. Europe Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 57. United States Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 58. Canada Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 59. Mexico Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 60. Brazil Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 61. China Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 62. Japan Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 63. Korea Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 65. India Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 66. Australia Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 67. Germany Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 68. France Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 69. UK Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 70. Italy Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 71. Russia Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 72. Egypt Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 73. South Africa Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 74. Israel Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 75. Turkey Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Antisense Oligonucleotides (ASO) Therapy Market Size 2025-2030 ($ millions)
Figure 77. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Antisense Oligonucleotides (ASO) Therapy Market Size Market Share Forecast by Application (2025-2030)
